Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

172 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Creating a plasma coordination center to support COVID-19 outpatient trials across a national network of hospital blood banks.
Yarava A, Marshall C, Reichert DE, Ye A, Khanal P, Robbins SH, Sachais BS, Oh D, Metcalf RA, Conry-Cantilena K, King K, Reyes M, Adamski J, Marques MB, Tran MH, Allen ES, Pach D, Blumberg N, Hobbs R, Nash T, Shenoy AG, Mosnaim GS, Fukuta Y, Patel B, Heath SL, Levine AC, Meisenberg BR, Anjan S, Huaman MA, Blair JE, Currier JS, Paxton JH, Rausch W, Oei K, Abinante M, Forthal DN, Zand MS, Kassaye SG, Cachay ER, Gebo KA, Shoham S, Casadevall A, McBee NA, Amirault D, Wang Y, Hopkins E, Shade DM, Layendecker O, Klein SL, Park HS, Lee JS, Caturegli P, Raval JS, Cruser D, Ziman AF, Gerber J, Gniadek TJ, Bloch EM, Tobian AAR, Hanley DF, Sullivan DJ, Lane K; CSSC (COVID 19 Serologic Studies Consortium) group. Yarava A, et al. Among authors: fukuta y. J Clin Transl Sci. 2024 Nov 14;8(1):e200. doi: 10.1017/cts.2024.642. eCollection 2024. J Clin Transl Sci. 2024. PMID: 39655012 Free PMC article.
Characterization and application of Lachancea thermotolerans isolates for sake brewing.
Nakatani M, Ohtani R, Umezawa K, Uchise T, Matsuo Y, Fukuta Y, Obata E, Katabuchi A, Kizaki K, Kitazume H, Ohashi M, Johzuka K, Kurata A, Uegaki K. Nakatani M, et al. Among authors: fukuta y. J Biosci Bioeng. 2025 Jan;139(1):30-35. doi: 10.1016/j.jbiosc.2024.10.004. Epub 2024 Nov 2. J Biosci Bioeng. 2025. PMID: 39489649
Real-world outcomes of ponatinib treatment in 724 patients with CML and Ph+ ALL: a post-marketing surveillance study with a special interest in arterial occlusive events in Japan.
Takahashi N, Kondo T, Ikari Y, Fukumoto Y, Hatake K, Masunari A, Nishibayashi S, Kageyama A, Fukuta Y, Tojo A. Takahashi N, et al. Among authors: fukuta y. Jpn J Clin Oncol. 2024 Aug 14;54(8):930-938. doi: 10.1093/jjco/hyae061. Jpn J Clin Oncol. 2024. PMID: 38747937 Free PMC article.
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial.
Park HS, Yin A, Barranta C, Lee JS, Caputo CA, Sachithanandham J, Li M, Yoon S, Sitaras I, Jedlicka A, Eby Y, Ram M, Fernandez RE, Baker OR, Shenoy AG, Mosnaim GS, Fukuta Y, Patel B, Heath SL, Levine AC, Meisenberg BR, Spivak ES, Anjan S, Huaman MA, Blair JE, Currier JS, Paxton JH, Gerber JM, Petrini JR, Broderick PB, Rausch W, Cordisco ME, Hammel J, Greenblatt B, Cluzet VC, Cruser D, Oei K, Abinante M, Hammitt LL, Sutcliffe CG, Forthal DN, Zand MS, Cachay ER, Raval JS, Kassaye SG, Marshall CE, Yarava A, Lane K, McBee NA, Gawad AL, Karlen N, Singh A, Ford DE, Jabs DA, Appel LJ, Shade DM, Lau B, Ehrhardt S, Baksh SN, Shapiro JR, Ou J, Na YB, Knoll MD, Ornelas-Gatdula E, Arroyo-Curras N, Gniadek TJ, Caturegli P, Wu J, Ndahiro N, Betenbaugh MJ, Ziman A, Hanley DF, Casadevall A, Shoham S, Bloch EM, Gebo KA, Tobian AA, Laeyendecker O, Pekosz A, Klein SL, Sullivan DJ. Park HS, et al. Among authors: fukuta y. JCI Insight. 2024 Mar 14;9(8):e178460. doi: 10.1172/jci.insight.178460. JCI Insight. 2024. PMID: 38483534 Free PMC article. Clinical Trial.
Erratum for Gebo et al., "Early antibody treatment, inflammation, and risk of post-COVID conditions".
Gebo KA, Heath SL, Fukuta Y, Zhu X, Baksh S, Abraham AG, Habtehyimer F, Shade D, Ruff J, Ram M, Laeyendecker O, Fernandez RE, Patel EU, Baker OR, Shoham S, Cachay ER, Currier JS, Gerber JM, Meisenberg B, Forthal DN, Hammitt LL, Huaman MA, Levine A, Mosnaim GS, Patel B, Paxton JH, Raval JS, Sutcliffe CG, Anjan S, Gniadek T, Kassaye S, Blair JE, Lane K, McBee NA, Gawad AL, Das P, Klein SL, Pekosz A, Bloch EM, Hanley D, Casadevall A, Tobian AAR, Sullivan DJ; CSSC-004 Consortium. Gebo KA, et al. Among authors: fukuta y. mBio. 2024 Jan 16;15(1):e0297923. doi: 10.1128/mbio.02979-23. Epub 2023 Dec 14. mBio. 2024. PMID: 38095433 Free PMC article. No abstract available.
COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial.
Habtehyimer F, Zhu X, Redd AD, Gebo KA, Abraham AG, Patel EU, Laeyendecker O, Gniadek TJ, Fernandez RE, Baker OR, Ram M, Cachay ER, Currier JS, Fukuta Y, Gerber JM, Heath SL, Meisenberg B, Huaman MA, Levine AC, Shenoy A, Anjan S, Blair JE, Cruser D, Forthal DN, Hammitt LL, Kassaye S, Mosnaim GS, Patel B, Paxton JH, Raval JS, Sutcliffe CG, Abinante M, Oei KS, Cluzet V, Cordisco ME, Greenblatt B, Rausch W, Shade D, Gawad AL, Klein SL, Pekosz A, Shoham S, Casadevall A, Bloch EM, Hanley D, Tobian AAR, Sullivan DJ. Habtehyimer F, et al. Among authors: fukuta y. Microbiol Spectr. 2024 Jan 11;12(1):e0328623. doi: 10.1128/spectrum.03286-23. Epub 2023 Nov 27. Microbiol Spectr. 2024. PMID: 38009954 Free PMC article. Clinical Trial.
172 results